U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1 Takeda announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the…
Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update Mirum Pharmaceuticals, Inc. a leading rare disease company, reported financial results for the second quarter 2026 and provided a business update. Mirum delivered another strong quarter, with continued…
ADM to Expand North America Crush Capacity Amid Strong Biofuel Demand ADM a global leader in innovative solutions from nature, announced a series of investments designed to expand North American oilseed crush capacity and strengthen the company’s ability to meet…
Eastern Technologies Launches COOLGARD Non-Phosphorus Chemistry Line for Industrial Cooling Water Eastern Technologies, Inc. a Sylmar company and custom formulator of industrial water treatment chemistries, today announced the launch of its COOLGARD Non-Phosphorus product line. The line gives ETI’s partners…
Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones Precision BioSciences, Inc. a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies…
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD bioAffinity Technologies, Inc. a biotechnology company advancing early-stage cancer diagnostics and targeted therapeutics, today announced a collaboration with Pictor®, Inc., a targeted proteomic platform company, to…
Cellares and Sonoma Biotherapeutics Collaborate to Automate Manufacturing of SBT-77-7101 Engineered Treg Cell Therapy on the Cell Shuttle® Platform Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T…
Insulet Accelerates Global Growth with Launch of Omnipod® 5 and Omnipod Discover™ in Spain, Expanding Access to Tubeless Diabetes Technology Insulet Corporation the global leader in tubeless insulin pump technology with its Omnipod® brand of products, announced the commercial launch of its Omnipod 5…
Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member Brenus Pharma announced key appointments to its board of directors. The company welcomes Eric DESSERTENNE as President & Chairman of…
Rezon Bio Appoints Dr. Hubert Scholze as Chief Business Officer to Accelerate Global Commercial Expansion Rezon Bio, a science-driven European biologics contract development and manufacturing organization (CDMO), announced the appointment of Dr. Hubert Scholze as Chief Business Officer (CBO), effective…
In Line With the LEAP | 28 Portfolio Rotation Strategy, Bureau Veritas Signs an Agreement to Sell Its Oil & Petrochemicals and Coal Testing and Inspection Business Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), announces…
ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development ICON plc announced that it has selected Microsoft as a preferred technology partner – further advancing ICON’s previously announced plan to invest in digital innovation and AI…